Ribavirin antagonizes the effect of azidothymidine on HIV replication - Wikidata - awgldk - TriplyDB

Ribavirin antagonizes the effect of azidothymidine on HIV replication

Ribavirin antagonizes the effect of azidothymidine on HIV replication

http://www.wikidata.org/entity/Q28337829

about

Inhibition of human immunodeficiency virus syncytium formation and virus replication by castanospermine Debio 025, a cyclophilin binding molecule, is highly efficient in clearing hepatitis C virus (HCV) replicon-containing cells when used alone or in combination with specifically targeted antiviral therapy for HCV (STAT-C) inhibitors Fast relapse and high drop out rate of 48 weeks daily interferon monotherapy in HIV-infected patients with chronic hepatitis C.Effect of ribavirin on intracellular and plasma pharmacokinetics of nucleoside reverse transcriptase inhibitors in patients with human immunodeficiency virus-hepatitis C virus coinfection: results of a randomized clinical study Ribavirin Antagonizes the In Vitro Anti-Hepatitis C Virus Activity of 2'-C-Methylcytidine, the Active Component of Valopicitabine Therapeutic issues in HIV/HCV-coinfected patients Coinfection with Hepatitis C Virus and Human Immunodeficiency Virus: Virological, Immunological, and Clinical Outcomes Ribavirin--current status of a broad spectrum antiviral agent Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons Anti-human immunodeficiency virus synergism by zidovudine (3'-azidothymidine) and didanosine (dideoxyinosine) contrasts with their additive inhibition of normal human marrow progenitor cells Synergistic inhibition of human immunodeficiency virus type 1 replication in vitro by two-drug and three-drug combinations of 3'-azido-3'-deoxythymidine, phosphonoformate, and 2',3'-dideoxythymidine Synergistic inhibition of human immunodeficiency virus type 1 replication by 5-ethyl-1-ethoxymethyl-6-(phenylthio)uracil (E-EPU) and azidothymidine in vitro Combinations of isoprinosine and 3'-azido-3'-deoxythymidine in lymphocytes infected with human immunodeficiency virus type 1 Susceptibility of human immunodeficiency virus type 1 replication in vitro to acyclic adenosine analogs and synergy of the analogs with 3'-azido-3'-deoxythymidine Inhibition of human immunodeficiency virus in vitro by combinations of 3'-azido-3'-deoxythymidine and foscarnet Structure-activity relationships of fluorinated nucleoside analogs and their synergistic effect in combination with phosphonoformate against human immunodeficiency virus type 1 Anti-human immunodeficiency virus agent 3'-azido-3'-deoxythymidine inhibits replication of Epstein-Barr virus Ribavirin antagonizes inhibitory effects of pyrimidine 2',3'-dideoxynucleosides but enhances inhibitory effects of purine 2',3'-dideoxynucleosides on replication of human immunodeficiency virus in vitro Synergistic and antagonistic drug combinations depend on network topology Challenges in the treatment of HIV and HCV coinfection.Phosphorylation of nucleoside analog antiretrovirals: a review for clinicians.Treatment of human immunodeficiency virus infections Abacavir does not influence the rate of virological response in HIV-HCV-coinfected patients treated with pegylated interferon and weight-adjusted ribavirin.Reciprocal interaction of human immunodeficiency virus and hepatitis C virus infections Vaccine and antiviral strategies against infections caused by human immunodeficiency virus.Coinfection with HIV and HCV: more questions than answers?Human immunodeficiency virus-hepatitis C coinfection: swapping new problems for newer ones.3-drug synergistic interactions of small molecular inhibitors of hepatitis C virus replication Hepatitis C and human immune deficiency coinfection at the era of highly active antiretroviral therapy.Treatment of hepatitis C and anemia in human immunodeficiency virus-infected patients.Hepatitis C and human immunodeficiency virus infection.Correlations between the in vitro and in vivo activity of anti-HIV agents: implications for future drug development.Treatment of HIV infection: the antiretroviral nucleoside analogues. Nucleoside analogues: combination therapy.Antiretroviral therapy: strategies beyond single-agent reverse transcriptase inhibition.Safety and efficacy of interferon-ribavirin combination therapy in HCV-HIV coinfected subjects: an early report.Antiviral therapy for human immunodeficiency virus infections Safety, tolerance, and pharmacokinetics of systemic ribavirin in children with human immunodeficiency virus infection.Ganciclovir antagonizes the anti-human immunodeficiency virus type 1 activity of zidovudine and didanosine in vitro.Update on Hepatitis C Virus and HIV Coinfection.Strategies in the treatment of AIDS and related diseases: the lessons of cancer chemotherapy.

P2860

Q24633025-E4E1DF7E-4004-4C77-BE45-80165B2C2F14 Q24645702-8FC71D77-E6D4-43CF-AF78-815E5645E009 Q24804388-EA247B3E-E717-4B58-A191-D2B564524CA0 Q27472607-E4866688-19CF-4E0F-AA47-7C5400ECAFEF Q27477522-03F6C21E-D6CE-443F-A58B-2DB69D47561A Q27481053-478A40E4-5E97-4277-A9CC-071811483D11 Q27488883-0C172862-A59F-4001-8A94-153069EDD366 Q28190105-EEE50639-21E8-4ADA-BD3F-0222B097CF40 Q28274676-D8FDAB76-696C-4038-BC65-D1CA818380AA Q28323830-D27A2DD5-18B3-4568-8E6E-BEED588A0F12 Q28324208-828BE115-9495-46D1-8069-FF3F3B0C208D Q28333682-EA1554A0-313E-4161-BB4F-F6C972E31300 Q28339702-166EF0F3-3F04-4D43-99A5-DE8D5129DE4A Q28340298-A3F662C8-3B9F-4A60-AF01-5622B6EE80D0 Q28341972-7FAD4469-87DF-4B15-8627-149ECB6CE489 Q28342189-F4A11EA4-7FC1-4494-9CDB-64022B9753C3 Q28359820-6036013C-1C7E-4237-A60E-FFF642A14BC6 Q28361577-B63FC83C-A4CA-4794-B066-B2A66861D209 Q28542101-033450E7-F6E2-487B-B81B-B2D6A0A15976 Q30389282-94408F90-B3EB-4AD2-BE00-909DF68F5E8B Q31975873-75DCE633-8ACE-4E1B-BC0E-99437FF117EC Q33740357-8E30B143-F943-4F11-8B43-6F4F9581937A Q33906382-7A82C1E1-F696-49CA-94EC-CB2B5E9E9FA7 Q33999381-AFCD1FAC-842F-4FCB-BA18-2EFE03A8C883 Q34101462-D7478B2B-1D7A-4D36-A44B-693441C5E6E2 Q34113786-DC3F4887-E804-4EB7-AE39-3BAC1E14C01B Q34390060-2D8ECFAF-074E-41A0-B240-1C61B30FDDA2 Q34440411-E40DF289-DC18-4780-9027-C85C2FB316B6 Q34536150-666543C1-7C13-4D92-8C8D-CDE267D8D828 Q34631679-A95CEA79-F807-4515-8250-A0ADBE3E92B5 Q34984125-8B44FCDF-6EC9-479A-9242-0FFC7DAB147B Q35174403-50F4B9C9-3EDD-4B4B-860C-93EB9111E879 Q35232016-DBB221F9-4166-45D4-86AE-DEFF3D7005DE Q35325810-92B2FA16-6D7D-4404-BCC2-1F6AD682D8CE Q35362117-1F595D00-F495-44E7-B2C3-1A1A13BB945B Q35366050-D7780176-47C2-4B5E-B4A5-2A8BC44BE4EF Q35810419-67191BCE-B6A6-4E9E-940D-9C6C9EE86900 Q35836636-1907DEFE-A8E4-4563-A055-FE84AF03F951 Q35906047-229864E8-AC82-4082-BC88-BE67A81275AA Q35930774-1F982956-7BC6-40F3-A9F4-8201BEA157C1

P2860

Ribavirin antagonizes the effect of azidothymidine on HIV replication

http://www.wikidata.org/entity/Q28337829

description

1987 nî lūn-bûn

@nan

1987 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

1987 թվականի մարտին հրատարակված գիտական հոդված

@hy

1987年の論文

@ja

1987年論文

@yue

1987年論文

@zh-hant

1987年論文

@zh-hk

1987年論文

@zh-mo

1987年論文

@zh-tw

1987年论文

@wuu

name

Ribavirin antagonizes the effect of azidothymidine on HIV replication

@ast

Ribavirin antagonizes the effect of azidothymidine on HIV replication

@en

Ribavirin antagonizes the effect of azidothymidine on HIV replication

@nl

type

label

Ribavirin antagonizes the effect of azidothymidine on HIV replication

@ast

Ribavirin antagonizes the effect of azidothymidine on HIV replication

@en

Ribavirin antagonizes the effect of azidothymidine on HIV replication

@nl

prefLabel

Ribavirin antagonizes the effect of azidothymidine on HIV replication

@ast

Ribavirin antagonizes the effect of azidothymidine on HIV replication

@en

Ribavirin antagonizes the effect of azidothymidine on HIV replication

@nl

P1433

Q28337829-5EC37F5C-998D-474D-9FC5-969338C3031C

P1476

Q28337829-4E75EC66-D342-478D-AB27-F9E30EB60ED6

P2093

Q28337829-339E47DD-3474-4F9B-A4B3-B38ECCC1A468

Q28337829-561C34D0-1764-4157-9651-44B19805E9B5

Q28337829-601D18CA-F698-4469-AF24-2CC75F545995

Q28337829-7DCA4E8C-7880-4A72-984C-8E981C1A6C0D

Q28337829-9A4A0614-F229-43EA-B6E5-147DC40DEF91

Q28337829-AAE9C62C-21E7-4AFA-AD48-6495789A9EB7

Q28337829-CB5CF16D-1F31-4DE2-B711-3E5B14233339

Q28337829-EA0DE03D-0987-47C8-A88D-4F93B7E1B45A

Q28337829-FEE4D35B-8DB8-4888-9617-C206E242E387

P2860

Q28337829-002467C0-5813-4902-A2A6-9F47379B8F3F

Q28337829-08E1EB2D-43A4-4D35-92B8-BC390E22BB53

Q28337829-08E6A53B-41D4-42F8-AE4F-DD7C61691F71

Q28337829-18FCF8ED-6BFB-4AF8-9853-359C3CB0B4DE

Q28337829-1F6FEAF5-7600-4F6C-B753-8218090DCE60

Q28337829-22F4C808-0C10-46EA-B6D2-44FBACF55497

Q28337829-2B8EFA8E-18B9-4028-84C6-894554D7509E

Q28337829-32ACD289-31DD-4D00-BB00-A529B6A1BB5A

Q28337829-33507DA2-C221-4959-9FB0-EF118147F2F3

Q28337829-6C17120E-9FD4-4DAB-A5CB-DA546CA540CC

P304

Q28337829-31B535AA-F421-48A8-9DE7-3661E0454468

P31

Q28337829-0364083D-2D8E-49E6-B9A6-8344A887F627

P356

Q28337829-EE54A62B-54E8-4119-B1BA-22CED475E936

P407

Q28337829-A014E87F-2952-4D1C-9081-AE204E64A1D5

P433

Q28337829-195DB1AC-4621-442B-A9CF-6EE12E92CC82

P478

Q28337829-DA4CEAC6-284A-4001-AC14-E8EC31BC3752

P577

Q28337829-2DA5347E-3F2B-42DB-B915-6AFAFF14AE22

P698

Q28337829-B2C2149B-3262-4A8B-8235-EE50C226B66C

P356

SCIENCE.2435003

P1433

P1476

Ribavirin antagonizes the effect of azidothymidine on HIV replication

@en

P2093

C Crumpacker

http://www.w3.org/2001/XMLSchema#string

J A Fyfe

http://www.w3.org/2001/XMLSchema#string

K L Hartshorn

http://www.w3.org/2001/XMLSchema#string

L A Coleman

http://www.w3.org/2001/XMLSchema#string

M S Hirsch

http://www.w3.org/2001/XMLSchema#string

M W Vogt

http://www.w3.org/2001/XMLSchema#string

P A Furman

http://www.w3.org/2001/XMLSchema#string

R T Schooley

http://www.w3.org/2001/XMLSchema#string

T C Chou

http://www.w3.org/2001/XMLSchema#string

P2860

Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS)

3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro

Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase

Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2',3'-dideoxynucleosides

Synergistic inhibition of human T-cell lymphotropic virus type III replication in vitro by phosphonoformate and recombinant alpha-A interferon

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS

Isolation of lymphocytopathic retroviruses from San Francisco patients with AIDS.

Administration of 3'-azido-3'-deoxythymidine, an inhibitor of HTLV-III/LAV replication, to patients with AIDS or AIDS-related complex.

Synergistic inhibition of human immunodeficiency virus in vitro by azidothymidine and recombinant alpha A interferon.

P304

1376-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1126/SCIENCE.2435003

http://www.w3.org/2001/XMLSchema#string

P407

P433

4794

http://www.w3.org/2001/XMLSchema#string

P478

235

http://www.w3.org/2001/XMLSchema#string

P577

1987-03-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

2435003

http://www.w3.org/2001/XMLSchema#string